Spremenjene variante IL-2, ki selektivno aktivirajo regulatorne T celice za zdravljenje avtoimunskih bolezni

• 收藏
• 分享

专利权人:

Delinia; Inc.

发明人:

GREVE Jeffrey

申请号：

SI201531284

公开号：

SI3482766T1

申请日:

2015.08.10

申请国别(地区):

SI

年份:

2020

代理人:

摘要：

The invention described herein is a novel IL-2 protein with selective agonist activity for Regulatory T cells and with an additional amino acid substitution that enable chemical conjugation with Polyethyene Glycol (PEG) that increase circulating half- life compared to the IL-2 selective agonist alone. A preferred IL-2 selective agonist variant is IL2/N88R/C125S/D109C.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/